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Abstract. Animal and human studies suggest that Schistosoma mansoni infection may increase risk of human immu-
nodeficiency virus (HIV) acquisition. Therefore, we tested 345 reproductive age women in rural Tanzanian villages near
Lake Victoria, where S. mansoni is hyperendemic, for sexually transmitted infections (STIs) and schistosomiasis by
circulating anodic antigen (CAA) serum assay. Over one-half (54%) had an active schistosome infection; 6% were HIV-
seropositive. By univariate analysis, only schistosome infection predicted HIV infection (odds ratio [OR] = 3.9, 95%
confidence interval = [1.3–12.0], P = 0.015) and remained significant using multivariate analysis to control for age, STIs,
and distance from the lake (OR = 6.2 [1.7–22.9], P = 0.006). HIV prevalence was higher among women with more intense
schistosome infections (P = 0.005), and the median schistosome intensity was higher in HIV-infected than -uninfected
women (400 versus 15 pg CAA/mL, P = 0.01). This finding suggests that S. mansoni infection may be a modifiable HIV risk
factor that places millions of people worldwide at increased risk of HIV acquisition.
INTRODUCTION
Schistosomiasis is caused by a parasitic infection that affects
over 200 million people worldwide, with approximately 85%
of cases in Africa.1,2 Previously, in a cross-sectional study of
Tanzanian women, we found that the odds of being infected
with human immunodeficiency virus (HIV) were fourfold
higher for subjects with Schistosoma haematobium infection
than subjects without S. haematobium,3 and we postulated that
the chronic genital inflammation caused by S. haematobium
eggs pre-disposes to HIV infection. We observed a similar
trend in women with S. mansoni infection, although the num-
bers were small, and the association did not reach statistical
significance (unpublished data). Primate models support the
hypothesis that S. mansoni infection predisposes to HIV infec-
tion. Rhesus macaques with active S. mansoni infection were
17 times more susceptible to simian HIV (SHIV) acquisition
after rectal inoculation than macaques without S. mansoni.4
Although a variety of interactions between S. mansoni and
HIV infection in humans have been described,5–10 a direct
association between active S. mansoni and HIV has not been
documented in humans. If S. mansoni is a risk factor for HIV
acquisition, this finding could have major implications for
HIV prevention work in much of the world.
We, therefore, performed a cross-sectional study to explore
the relationship between S. mansoni and HIV infections in
women living on the shores of Lake Victoria, including screen-
ing for other genital tract infections, which are well-known HIV
risk factors, to adjust our analysis for any possible confounders.
The screening of large numbers of women in S. mansoni-
endemic villages was facilitated by the use of a sensitive and
specific serum test for the diagnosis of Schistosoma infection.
The circulating anodic antigen (CAA) test detects a Schistosoma
worm antigen in the serum, and it is 80–95% sensitive and 98–
100% specific for diagnosis of schistosomiasis.11–13 CAA is a
highly glycosylated excretory antigen originating from the par-
asite gut and released into the host blood circulation when the
worm regurgitates the undigested compounds of the gut.14
Schistosome circulating antigen detection performs well in
both HIV-negative and -positive individuals,9 and it is recog-
nized by the World Health Organization as an alternative diag-
nostic method to parasitologic examination of multiple stool
or urine samples.15,16
MATERIALS ANDMETHODS
Study sites and subjects. This study was conducted in seven
rural villages with high rates of both S. mansoni and HIV,
chosen for their locations at a distance of 1–25 km from Lake
Victoria in western Tanzania (Figure 1). Lake Victoria is
infested with the Biomphalaria snail, the intermediate host of
S. mansoni, and inhabitants of the study sites have among the
highest prevalence of S. mansoni infection in the world.
Repeat surveys conducted by our group between 1999 and
2011 have documented a high prevalence of S. mansoni in
these villages; in contrast, the prevalence of S. haematobium
is < 3% in adults in the same villages.3,17–20 HIV is also prev-
alent in these villages; a 2004 study showed that 8% of adults
greater than 15 years of age were HIV-infected.21 The major
mode of HIV transmission is heterosexual intercourse, and
there are more females than males infected, with a female to
male ratio of HIV infection of 1.2:1.0.21
We recruited women ages 18–50 years who were seeking
routine pre-natal, post-natal, or pediatric care for themselves
or their newborn children in the seven study villages. The
study team visited each of the health posts for 1 week between
January of 2010 and August of 2011 and invited consecutive
women at the posts to participate in the study.
Study procedures and sample collection. The study included
an oral questionnaire, a gynecologic exam, and phlebotomy.
Gynecologic examinations included wet preparations, which
were examined on-site for diagnoses of Trichomonas vaginalis,
Candida species, and bacterial vaginosis by the criteria in the
work by Amsel and others.22 Endocervical swabs were col-
lected for Chlamydia trachomatis and Neisseria gonorrhoeae
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testing at the laboratory of the National Institute for Medical
Research (NIMR) in Mwanza, Tanzania. Venous blood was
also collected, and serum was separated and stored at –20°C
at the NIMR laboratory. Testing for syphilis and preparation
of a portion of CAA test strips were performed at NIMR.
Additional test strip preparation and all test strip reading were
performed at the Leiden University Medical Center.
Women were offered on-site voluntary HIV counseling and
testing in Kiswahili by a trained nurse counselor. Rapid tests
(SD Bioline; Standard Diagnostics, Inc., Kyonggi-do, South
Korea) were used with confirmatory testing by a second test
(Alere Determine; Inverness Medical, Princeton, NJ) as per
the national testing algorithm, and patients received their
results and post-test counseling on the same day.
Patients diagnosed with HIV were referred to the local HIV
clinic for free care and treatment. Women with trichomoniasis,
candidiasis, or bacterial vaginosis were provided treatment
on the same day. Women who tested positive for gonorrhea,
Chlamydia, syphilis, or schistosomiasis were treated at a follow-
up visit as soon as laboratory results were available.
Laboratory analyses. Schistosoma. CAA is a glycoprotein
that is produced by gut epithelial cells of schistosomal
worms14 and secreted in large quantities into the host blood-
stream during active infection.23 The CAA test does not dis-
tinguish S. haematobium from S. mansoni infection. The test
usually becomes negative within 1 week of successful anti-
schistosomal therapy.24
CAA testing was performed using the upconverting phos-
phor (UCP) technology lateral flow assay as previously
described.12 Serum was treated with 4% (wt/vol) trichloro-
acetic acid to remove proteins and antibody complexes.
After centrifugation, the supernatant was mixed with an assay
buffer containing an anti-CAA mouse monoclonal antibody
conjugated to UCP reporter particles and incubated for 1 hour
at 37°C. The mixture was applied to a lateral flow test strip
with a capture line of the same antibody, and chromatography
was permitted to continue until strips were dry. Strips were
read using a modified Packard Fluorocount meter, and test
line results were normalized to the control line results for
each test strip. A CAA value ³ 10 pg/mL was considered
positive based on a series of negative controls (highest value
plus 2 SDs). CAA values were stratified by intensity as greater
or less than 3,000 pg/mL, which represents approximately
100 eggs per 1 gram of stool.25
C. trachomatis and N. gonorrhoeae. DNA was extracted
from endocervical swab specimens and tested for C. trachomatis
and N. gonorrhoeae using Amplicor CT/NG specimen prepara-
tion, amplification, internal control, and detection kits (Roche
Molecular Systems, Branchburg, NJ). Gonorrhea results were
confirmed using 16S rRNA PCR testing.
Syphilis serology. Serum was tested for syphilis using the
Rapid Plasma Reagin (RPR) test, with confirmation of posi-
tive RPR results by the Treponema pallidum Particle Agglu-
tination assay (TPPA).
Ethics. The study was approved by the Institutional Review
Boards at Bugando Medical Center and Weill Cornell Medi-
cal College and the National Institute for Medical Research
in Tanzania. All women were informed about the study by a
nurse fluent in Kiswahili and provided written informed
consent before participation.
Statistical methods. Data were entered into a REDCap
database (Vanderbilt University, Nashville, TN) and analyzed
using Stata version 11 (Stata Corporation, College Station,
TX). Continuous variables were summarized by median and
interquartile range (IQR), and categorical variables were
summarized by frequency and percentage. Simple logistic
regression (for univariate analysis) followed by multiple logis-
tic regression (for multivariate analysis) were used to examine
factors associated with HIV. In multiple logistic regression
models, comprehensive adjustment was not pursued, because
it yielded failure in convergence. Associations between fac-
tors and the endpoint were summarized using odds ratios
(ORs) with 95% confidence intervals (CIs) and associated
P values. In regression analyses, age and distance from the
lake were analyzed as continuous variables, whereas other
variables were analyzed as binary variables.
We also compared the intensity of schistosome infection
between the HIV-positive and -negative groups using the
non-parametric Wilcoxon test (because of severe non-normality
of this data) and the non-parametric Jonckheere–Terpstra (JT)
Figure 1. Lake Victoria, surrounding countries, and the Mwanza
study area (shaded).
Table 1
Baseline characteristics of 345 women in S. mansoni-endemic villages
near Lake Victoria in Tanzania
Characteristic Value
Age in years
Median 30
IQR 24–36
Number of living children
Median 4
IQR 2–6
Reports more than one sexual partner
in the past 6 months
12 (5%)
Reports no current sexual partner 23 (9%)
History of miscarriage 116 (39%)
Distance of village from
Lake Victoria (km)
0–8 123 (36%)
9–17 125 (36%)
18–25 97 (28%)
Daily contact with potentially infectious water 344 (99%)
Never previously treated for schistosomiasis 178 (52%)
Never previously tested for HIV 114 (42%)
Non-missing data were included in each calculation.
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trend test.26 Two-sided hypotheses/tests were assumed for
calculation of all CIs and P values.
RESULTS
Patient characteristics. We invited 432 eligible women liv-
ing in seven villages within 25 km of Lake Victoria to partic-
ipate. Of these women, 345 (80%) women provided informed
consent and completed all study procedures.
The median age in this population was 30 years (IQR = 24–
36) (Table 1). All but one woman reported contact with
potentially contaminated water at least daily. Over three-
fourths of women had not been treated for schistosomiasis in
the past 5 years, and more than one-half of women had never
been treated.
Prevalence of schistosomiasis, genital tract infections,
and HIV. We diagnosed active schistosomiasis in 185 (54%)
women in this study population (Table 2). Among those
women harboring a schistosome infection, the median CAA
value was 446 pg/mL (IQR = 86–2,338); 21 of 345 (6%)
women were HIV-infected. The prevalence of other gyneco-
logic infections ranged from gonorrhea in 1 (< 1%) woman to
reactive syphilis serology in 26 (8%) women (Table 2).
Factors associated with schistosome infection. In both uni-
variate and multivariate analysis, distance from Lake Victoria
was the only factor that was significantly associated with
schistosome infection, with an OR of 0.95 (0.92–0.97) for each
increasing kilometer away from the lake (P < 0.001) (Table 3).
The highest prevalence was 81% in a village situated < 1 km
from the shore of Lake Victoria, whereas the lowest preva-
lence (38–42%) was observed in villages that were 12–22 km
inland. Age, prior receipt of praziquantel, and genital tract
infections did not significantly predict whether women were
currently infected with schistosomes.
Factors associated with HIV infection. Schistosome infec-
tion was significantly associated with HIV infection, whereas
other factors were not. Of 185 women with positive CAA levels,
17 (9%) women were HIV-infected, whereas of 160 women
without detectable CAA, 4 (3%) women were HIV-infected
(OR = 3.9 [95% CI = 1.3–12.0], P = 0.015) (Table 4). The ORs
for Chlamydia and syphilis were both 2.4, although neither was
statistically significant. The OR for each increasing 1 year of
age was 1.00 (0.95–1.06; P = 0.90). The OR for each increasing
1 km away from Lake Victoria, which correlates with living
closer to major roads, was 1.01 (0.95–1.07; P = 0.71). In multi-
variate analysis, schistosome infection was the single best pre-
dictor of HIV infection. Other variables were not significant
and did not affect the relationship between Schistosoma and
HIV infection. Specifically, when multiple regression models
were used to control for age, sexually transmitted infections
(STIs), and distance from the lake, the association between
Schistosoma and HIV remained statistically significant with an
OR of 6.2 (1.7–22.9; P = 0.006).
The median intensity of schistosome infection was signifi-
cantly higher among HIV-infected than -uninfected women
(400 versus 15 pg/mL, P = 0.01). When women were stratified
by CAA intensity, the prevalence of HIV infection significantly
increased among groups (P = 0.005 by JT test) (Figure 2).
Factors associated with other STIs. Cervicitis caused by
gonorrhea and/or Chlamydia was significantly associated with
younger age (OR = 0.87 [0.79–0.96] for each increasing year of
age, P = 0.006). No other significant associations were observed.
DISCUSSION
In women living in S. mansoni-endemic areas near Lake
Victoria, more than one-half were schistosome-infected, and
Schistosoma infection was strongly associated with HIV. This
finding suggests that S. mansoni infection and the chronic
inflammation from the gut caused by S. mansoni eggs may be
a risk factor for HIV acquisition. Schistosomiasis may be
placing millions of women throughout sub-Saharan Africa at
increased risk of becoming HIV-infected, and mass therapy of
women of reproductive age for schistosomiasis may be an
effective HIV prevention strategy.
Animal models support the hypothesis that S. mansoni infec-
tion increases host susceptibility to HIV infection. Studies in
macaques showed that the rectal inoculum of SHIV required
for SHIV acquisition was 17 times lower in macaques with than
without S. mansoni infection.4 In contrast, prior S. mansoni
infection did not significantly change the required infectious
dose when SHIV was inoculated intravenously.4,27 Researchers
postulated that S. mansoni infection increased the number of
activated CD4+ T cells in the gut-associated lymphoid tissue
(GALT) and thereby increased the optimal targets for SHIV
infection. Mouse models of schistosomiasis show that S. mansoni
eggs induce a Th17 CD4+ T-cell response in the gut mucosa.28,29
A growing body of literature suggests that HIV preferentially
infects Th17 CD4+ T cells in gut and genital tissue mucosa and
that increased numbers of these cells may increase susceptibility
to HIV infection.30,31 Additional human studies are needed
Table 2
Prevalence of infections in 345 rural Tanzanian women
Infection Prevalence
Schistosomiasis 185 (54%)
HIV-1 21 (6%)
Syphilis 26 (8%)
Gonorrhea 1 (0.3%)
Chlamydia 15 (4%)
Trichomoniasis 4 (1%)
Bacterial vaginosis 19 (6%)
Candidiasis 15 (4%)
Table 3
Associations of potential risk factors with schistosome infection (univariate analysis)
Potential risk factor
Schistosomiasis-positive
(N = 185)
Schistosomiasis-negative
(N = 160)
OR for association with
schistosome infection (95% CI) P value
Median age (IQR) 30 (25–36) 29 (23–37) 1.02 (0.99–1.05) 0.15
Received praziquantel in past 5 years 21 (19%) 16 (15%) 1.4 (0.7–2.9) 0.35
Gonorrhea and/or Chlamydia cervicitis 7 (4%) 9 (6%) 0.7 (0.2–1.8) 0.42
Syphilis 17 (10%) 9 (6%) 1.8 (0.8–4.0) 0.19
Median kilometers from Lake Victoria (IQR) 10 (1–14) 12 (8–22) 0.95 (0.92–0.97) < 0.001
Non-missing data were included in each calculation.
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to determine if S. mansoni eggs induce a Th17 cell immune
response in the GALT and if these Th17 cells express HIV
susceptibility factors, such as CC Chemokine Receptor 5
(CCR5) and integrin a4b7.
Our work is also supported by recent findings from the
Rakai region of Uganda, where S. mansoni is endemic.32 As
noted perceptively in the work by Secor,33 HIV-infected indi-
viduals more often had antibodies to schistosome antigens than
HIV-uninfected individuals. Unlike in our study, in which
CAA positivity indicates live worm infestation, the detection
of antibodies to schistosome antigens does not prove active
schistosomiasis. Coupled with our findings, this population-
based study lends additional clinical support to our finding that
S. mansoni infection and not only S. haematobium infection
(as previously reported) is associated with HIV.
In addition, S. mansoni-infected individuals displayed higher
densities of the HIV chemokine receptors CCR5 and CXCR4
on their CD4+ T cells and monocytes than individuals with
schistosomiasis that had been previously treated.34 S. mansoni
infection was also shown to increase the HIV RNA viral load
in HIV-positive patients with untreated S. mansoni infection
compared with patients with S. mansoni infections that had
been treated.35 Several earlier non-randomized studies did not
find an effect of praziquantel treatment on viral load,5,6,36,37 but
this result has been postulated to be caused by transient
increases in the schistosomiasis-conducive Th2 environment
immediately after treatment.5,38 S.mansoni-infected individuals
are also reported to excrete fewer ova than individuals without
HIV.7,10 Our results support these findings that show complex
interactions between Schistosoma andHIV infections as well as
the growing consensus that schistosome infection, including
S.mansoni, may be a risk factor for HIV acquisition.1,33
Our work suggests that, among rural African women in
whom the prevalence of genital tract infections is low, schis-
tosome infection may be a major contributor of risk for HIV
acquisition. Over one-half of our population was infected with
schistosomes, leading to an estimated population-attributable
fraction for HIV acquisition caused by schistosome infection
of 69% (36–81%) using previously described methods.39 In
contrast, the population-attributable fractions for genital tract
infections in our population were 7% and below. The direc-
tion of our findings supports the well-described association
between HIV and STIs, but the inability of our study to show
statistical significance may be caused by the low prevalence of
STIs in this rural population. We postulate that, in our popu-
lation and other rural populations with few traditional HIV
risk factors, such as multiple sexual partners and high rates of
genital tract infections, schistosome infection may play a role
as a key driver of HIV transmission. Of note, this study
addresses the risk only in women aged 18–50 years who were
seen at rural health clinics, and it does not address whether
men or younger adolescent girls are also at increased risk.
The CAA test is a valuable diagnostic test for schistosome
infections. The antigen becomes detectable in serum approxi-
mately 5 weeks after infection.40 CAA levels fall rapidly post-
treatment, with a serum half-life of 2 days,24 and they rise with
reinfection.41 The test is, therefore, highly time-specific for
active schistosome infections. CAA assays have been recom-
mended for serologic screening programs, in which repeated
parasitologic examinations of urine and stool are logistically
complicated.42 The CAA test has recently been developed into
a very sensitive, robust lateral flow strip test, making test per-
formance in rural settings increasingly feasible.12 The test is
unable to distinguish between species of schistosomal infec-
tions. Therefore, projects relying on CAA testing either will
only allow species-specific conclusions when performed in
regions with sharp geographic demarcation of schistosome
species, like in our study, or will not be able to differentiate
between schistosome species.
Schistosomiasis is usually acquired in childhood, infecting
50–90% of children living in endemic areas by early adoles-
cence.2 Thus, acquisition of schistosome worms typically pre-
dates sexual activity and concomitant exposure to HIV.
The World Health Organization recommends that children
in endemic areas receive targeted, periodic school-based
Table 4
Associations of potential risk factors with HIV infection (univariate analysis)
Potential risk factor
HIV-positive
(N = 21)
HIV-negative
(N = 324)
OR for association with
HIV infection (95% CI) P value
Median age (IQR) 32 (25–36) 30 (24–36) 1.00 (0.95–1.06) 0.90
Median kilometers from Lake Victoria (IQR) 12 (10–22) 10 (8–22) 1.01 (0.95–1.07) 0.71
Chlamydia infection 2 (10%) 13 (4%) 2.4 (0.5–11.4) 0.27
Gonorrhea infection 0 1 (3%) – –
Positive syphilis serology 3 (16%) 23 (7%) 2.4 (0.6–8.7) 0.19
Trichomonas infection 0 4 (1%) – –
Bacterial vaginosis 0 19 (6%) – –
Candidal infection 0 15 (5%) – –
Schistosome infection 17 (81%) 168 (52%) 3.9 (1.3–12.0) 0.015
Non-missing data were included in each calculation. For age and kilometers from the lake, the OR corresponds to the OR estimate for one unit increase in the exposure (i.e., per 1-year increase
in age and 1-km increase in distance).
Figure 2. Prevalence of HIV infection by intensity of schistosome
infection as determined by serum CAA concentration.
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praziquantel treatment.1 Women do not often receive mass
treatment. In our population, more than one-half of women
had never received antischistosomal treatment, despite living
in a hyperendemic area and coming into daily contact with
unclean water. A policy of routine periodic praziquantel
administration for women seeking reproductive healthcare
services (including family planning, cervical cancer screening,
and pre-natal/post-natal care) would be a safe,1 efficient, and
inexpensive way to control schistosomiasis and, moreover,
potentially to preventHIVacquisition in this vulnerable group.
This cross-sectional study shows a strong association but
does not prove a causal role of schistosomiasis in HIV acquisi-
tion. An interventional trial would be necessary to show
causality. However, we feel that the best explanation of our
findings is that pre-existing schistosome infection modifies
mucosal immunity and predisposes to HIV infection. The
highest incidence of schistosome infection typically occurs in
childhood between the ages of 5 and 15 years, and in individ-
uals with ongoing exposure, it produces a chronic infection
over decades. More than 80% of our study participants denied
receiving praziquantel in the past 5 years, and more than one-
half reported never being treated. Therefore, it seems most
likely that the large proportion of our study participants had
chronic, untreated schistosome infection that pre-dated their
exposure to HIV. Although it is conversely possible that HIV
infection increases susceptibility to schistosomiasis,43 the for-
mer explanation for the association most aptly combines both
natural history and biological plausibility data. Also, it should
be noted that the use of ORs in this study could possibly
overestimate the relationship between HIV and schistosome
infection compared with relative risk because of the fact that
schistosome infection was common in our population.44
In conclusion, more than one-half of rural Tanzanian women
seen at health posts in S. mansoni-endemic areas of the Lake
Victoria region had evidence of active schistosome infection,
and the prevalence of HIV among these women was markedly
higher than among those women without schistosome infec-
tion. Active S. mansoni infection may be a modifiable HIV risk
factor that is contributing to high rates of new HIV infections
among millions of women living in sub-Saharan Africa.
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